Diagnose underlying cardiac diseases contributing to reduced cardiac function through advanced tissue characterization analyses. Detect scar tissue with LGE imaging, identify edema with T2-weighted imaging, and assess perfusion with stress imaging. Additionally, mapping sequences help differentiate between various cardiac pathologies, providing a comprehensive diagnostic approach.
T1 and Extracellular Volume (ECV) mapping enable quantitative assessment of myocardial tissue, providing objective biomarkers that complement conventional cardiovascular MR imaging. By measuring native T1 relaxation times and quantifying the extracellular space, these techniques help identify diffuse myocardial abnormalities that may not be visible on standard imaging alone. Integrated within Medis Suite MR, T1 & ECV Mapping streamlines tissue characterization with an automated, transparent workflow that supports confident diagnosis, disease characterization and longitudinal follow-up.
1The ECV functionality is for research
use only in CE countries.
T2 and/or T2* decay times based on the drawn region of interest, with color overlays indicating values. Identify edema with T2 and/or iron overload with T2* sequences in heart and liver.
Assess infarct size via late gadolinium enhancement (LGE). Visually assess or quantify using methods like Full Width at Half Maximum (FWHM) or Standard Deviations (SD). Determine infarct transmurality for severity
Simultaneously review rest and stress series to assess perfusion defects. Automatically measures as relative upslope and time to 50% max are given in a 16-segment model for precise quantification.
Easily calculate T2 and/or T2* parametric maps, providing values based on the AHA 16 segments or user-defined regions of interest. Identify areas of edema (in case of T2 sequence) or iron overload (in case of a T2* sequence) with precision.
You are only 1 click away from having your demo with an experienced Medis Suite MR product specialist.
